Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
Cureus
|
May 6, 2026
Serum Uric Acid as a Biomarker of Disease Severity in Children With Complicated Malaria: A Cross-Sectional Study From Eastern India
Mukesh Kumar, Sunanda Jha, Hansraj Kumar, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
August 21, 2015
Modeling population heterogeneity in viral dynamics for chronic hepatitis C infection: Insights from Phase 3 telaprevir clinical studies
Eric L Haseltine, Holly Kimko, Haobin Luo, et al.
British Journal of Clinical Pharmacology
|
May 31, 2012
The effect of CYP3A inhibitors and inducers on the pharmacokinetics of telaprevir in healthy volunteers
Varun Garg, Gurudatt Chandorkar, Yijun Yang, et al.
ERJ Open Research
|
March 18, 2026
A phase 1 pharmacokinetics study of deupirfenidone (LYT-100) in healthy older adults
Toby M Maher, Michael C Chen, Chris C Korth, et al.
Journal of Cardiovascular Electrophysiology
|
October 19, 2021
Physiologic lead placement with electroanatomic mapping: A case series
Jayson R Baman, Varun Garg, Aravind G Kalluri, et al.
Plos Computational Biology
|
January 14, 2012
A viral dynamic model for treatment regimens with direct-acting antivirals for chronic hepatitis C infection
Bambang S Adiwijaya, Tara L Kieffer, Joshua Henshaw, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
September 5, 2020
Pharmacokinetic and pharmacodynamic evaluation of Solid self-nanoemulsifying delivery system (SSNEDDS) loaded with curcumin and duloxetine in attenuation of neuropathic pain in rats
Bimlesh Kumar, Sachin Kumar Singh, T Prakash, et al.
Antimicrobial Agents and Chemotherapy
|
March 13, 2013
Pharmacokinetic interaction between telaprevir and methadone
Rolf van Heeswijk, Peter Verboven, Ann Vandevoorde, et al.
Journal of Hepatology
|
July 17, 2007
Phase 2 study of the combination of merimepodib with peginterferon-alpha2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C
Patrick Marcellin, Yves Horsmans, Frederik Nevens, et al.
Gynecologic Oncology
|
September 10, 2002
A phase II study of the MDR inhibitor biricodar (INCEL, VX-710) and paclitaxel in women with advanced ovarian cancer refractory to paclitaxel therapy
Michael V Seiden, Kenneth D Swenerton, Ursula Matulonis, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
Cureus
|
May 6, 2026
Serum Uric Acid as a Biomarker of Disease Severity in Children With Complicated Malaria: A Cross-Sectional Study From Eastern India
Mukesh Kumar, Sunanda Jha, Hansraj Kumar, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
August 21, 2015
Modeling population heterogeneity in viral dynamics for chronic hepatitis C infection: Insights from Phase 3 telaprevir clinical studies
Eric L Haseltine, Holly Kimko, Haobin Luo, et al.
British Journal of Clinical Pharmacology
|
May 31, 2012
The effect of CYP3A inhibitors and inducers on the pharmacokinetics of telaprevir in healthy volunteers
Varun Garg, Gurudatt Chandorkar, Yijun Yang, et al.
ERJ Open Research
|
March 18, 2026
A phase 1 pharmacokinetics study of deupirfenidone (LYT-100) in healthy older adults
Toby M Maher, Michael C Chen, Chris C Korth, et al.
Journal of Cardiovascular Electrophysiology
|
October 19, 2021
Physiologic lead placement with electroanatomic mapping: A case series
Jayson R Baman, Varun Garg, Aravind G Kalluri, et al.
Plos Computational Biology
|
January 14, 2012
A viral dynamic model for treatment regimens with direct-acting antivirals for chronic hepatitis C infection
Bambang S Adiwijaya, Tara L Kieffer, Joshua Henshaw, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
September 5, 2020
Pharmacokinetic and pharmacodynamic evaluation of Solid self-nanoemulsifying delivery system (SSNEDDS) loaded with curcumin and duloxetine in attenuation of neuropathic pain in rats
Bimlesh Kumar, Sachin Kumar Singh, T Prakash, et al.
Antimicrobial Agents and Chemotherapy
|
March 13, 2013
Pharmacokinetic interaction between telaprevir and methadone
Rolf van Heeswijk, Peter Verboven, Ann Vandevoorde, et al.
Journal of Hepatology
|
July 17, 2007
Phase 2 study of the combination of merimepodib with peginterferon-alpha2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C
Patrick Marcellin, Yves Horsmans, Frederik Nevens, et al.
Gynecologic Oncology
|
September 10, 2002
A phase II study of the MDR inhibitor biricodar (INCEL, VX-710) and paclitaxel in women with advanced ovarian cancer refractory to paclitaxel therapy
Michael V Seiden, Kenneth D Swenerton, Ursula Matulonis, et al.
Page
of 8